AltTox.org

Non-animal Methods for Toxicity Testing

References: Zhang, Panzica-Kelly & Augustine-Rauch


Last Updated: July 29, 2009
Print |
Email

Asada, H., Kawamura, Y., et al. (1997). Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 94(12), 6496-6499.

Augustine-Rauch, K.A., Zhang, Q., Kleinman, M., Lawton, R. & Welsh, M.J. (2004a). A study of vehicles for dosing cultured rodent embryos with non-aqueous soluble compounds. Reprod. Toxicol. 18, 391-398.

Augustine-Rauch, K.A., Zhang, Q.J., Leonard, J.L., Chadderton, A., Welsh, M.J., Rami, HK, et al. (2004b). Evidence for a molecular mechanism of teratogenicity of SB-236057, a 5-HT1B receptor inverse agonist that alters axial formation. Birth Defects Res. Part A Clin. Mol. Teratol. 70, 89-807.

Bournias-Vardiabasis, N. & Teplitz, R.L. (1982). Use of Drosophila embryo cell cultures as an in vitro teratogen assay. Teratog. Carcinog. Mutagen. 2(3-4), 333-341.

Brannen, K.C., Panzica-Kelly, J., Charlap, J.H. & Augustine-Rauch, K.A. (2008). Zebrafish: A non-mammalian model of developmental toxicology. Chapter 8. Developmental Toxicity in the Target Organ Series. Raven Press; B. Abbott and D. Hansen, eds.

Brannen, K.C., Panzica-Kelly, J., Danberry, T., & Augustine-Rauch, K. (Submitted). Validation of a Zebrafish embryo teratogenicity assay utilizing a quantitative prediction model.

Brown, N.A. & Fabro, S. (1981). Quantitation of rat embryonic development in vitro: A morphological scoring system. Teratology. 24(1), 65-78.

Chapin, R., Augustine-Rauch, K., et al. (2008). State of the art in developmental toxicity screening methods and a way forward: A meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res. B Dev. Reprod. Toxicol. 83(4), 446-456.

Cicurel, L. & Schmid, B.P. (1988). Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds. Experientia. 44(10), 833-840.

Cockroft, D.L. (1988). Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture. Teratology. 38(3), 281-290.

Driever, W., Solnica-Krezel, L., et al. (1996). A genetic screen for mutations affecting embryogenesis in zebrafish. Development. 123, 37-46.

Ellington, S.K. (1983). Effects of calcium on the growth of the rat conceptus during organogenesis in vitro. J. Reprod. Fertil. 67(2), 327-334.

Ellington, S.K. (1987). In vitro analysis of glucose metabolism and embryonic growth in postimplantation rat embryos. Development. 100(3), 431-439.

Festag, M., Viertel, B., et al. (2007). An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds. Toxicol. In Vitro. 21(8), 1631-1640.

Fort, D.J., Stover, E.L., et al. (1998). Phase III interlaboratory study of FETAX, Part 2: Interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay—Xenopus (FETAX). Drug Chem. Toxicol. 21(1), 1-14.

Fort, D.J., Rogers, R.L., et al. (2004). Comparative sensitivity of Xenopus tropicalis and Xenopus laevis as test species for the FETAX model. J. Appl. Toxicol. 24(6), 443-457.

Franklin, A.W. (1962). Thalidomide babies. Memorandum from the British Paediatric Association. Br. Med. J. 2(5303), 522-524.

Fujinaga, M., Mazze, R.I., et al. (1988). Rat whole embryo culture: An in vitro model for testing nitrous oxide teratogenicity. Anesthesiology. 69(3), 401-404.

Genschow, E., Spielmann, H., et al. (2002). The ECVAM international validation study on in vitro embryotoxicity tests: Results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern. Lab. Anim. 30(2), 151-176.

Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., et al. (2004). Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab. Anim. 32(3), 209-244.

Gillis, L. (1962). Thalidomide babies: Management of limb defects. Br. Med. J. 2(5305), 647-651.

Haffter, P., Granato, M., et al. (1996). The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development. 123, 1-36.

Hunter, III, E.S., Sadler, T.W. & Wynn, R.E. (1987). A potential mechanism of DL-beta-hydroxybutyrate-induced malformations in mouse embryos. Am. J. Physiol. 253(1 Pt 1), E72-80.

Knaut, H., Steinbeisser, H., et al. (2002). An evolutionary conserved region in the vasa 3'UTR targets RNA translation to the germ cells in the zebrafish. Curr. Biol. 12(6), 454-466.

Lenz, W. & Knapp, K. (1962). Thalidomide embryopathy. Arch. Environ. Health. 5, 100-105.

Lilienblum, W., Dekant, W., et al. (2008). Alternative methods to safety studies in experimental animals: Role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Arch. Toxicol. 82(4), 211-236.

Nagel, R. (2002). DarT: The embryo test with the Zebrafish Danio rerio—a general model in ecotoxicology and toxicology. ALTEX. 19, Suppl 1, 38-48.

New, D.A. (1978). Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. Camb. Philos. Soc. 53(1), 81-122.

New, D.A. (1983). In vitro culture of embryo and fetus. Proc. Annu. Symp. Eugen. Soc. 19, 163-176.

Raabe, M., Flynn, L.M., et al. (1998). Knockout of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl. Acad. Sci. U.S.A. 95(15), 8686-8691.

Sadler, T.W., Horton, W.E., et al. (1982). Whole embryo culture: A screening technique for teratogens? Teratog. Carcinog. Mutagen. 2(3-4), 243-253.

Schmid, B.P., Goulding, E., et al. (1981). Assessment of the teratogenic potential of acrolein and cyclophosphamide in a rat embryo culture system. Toxicology. 22(3), 235-243.

Schmid, B.P., Trippmacher, A., et al. (1983). Validation of the whole-embryo culture method for in vitro teratogenicity testing. Dev. Toxicol. Environ. Sci. 11, 563-566.

Seiler, A., Visan, A., et al. (2004). Improvement of an in vitro stem cell assay for developmental toxicity: The use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol. 18(2), 231-240.

Spence, S., Anderson, C., et al. (1999). Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod. Toxicol. 13(1), 15-29.

Spielmann, H., Pohl, I., Doering, B., Liebsch, M. & Moldenhauer, F. (1997). The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicology. 10, 119-127.

Spielmann, H., Genschow, E., et al. (2001). Preliminary results of the ECVAM validation study on three in vitro embryotoxicity tests. Altern. Lab. Anim. 29(3), 301-303.

Spielmann, H. & Liebsch, M. (2001). Lessons learned from validation of in vitro toxicity test: From failure to acceptance into regulatory practice. Toxicol. In Vitro. 15(4-5), 585-590.

Spielmann, H. (2005). Predicting the risk of developmental toxicity from in vitro assays. Toxicol. Appl. Pharmacol. 207, S375-S380.

Steele, C.E., New, D.A., et al. (1983). Teratogenic action of hypolipidemic agents: An in vitro study with postimplantation rat embryos. Teratology. 28(2), 229-236.

Streisinger, G., Walker, C., et al. (1981). Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature. 291(5813), 293-296.

Treinen, K.A., Louden, C., et al. (1999). Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. Teratology. 59(1), 51-59.

van Dartel, D.A., Pennings, J.L., et al. (2009). Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate. Reprod. Toxicol. 27(2), 93-102.

zur Nieden, N.I., Kempka, G., et al. (2004). Molecular multiple endpoint embryonic stem cell test—a possible approach to test for the teratogenic potential of compounds. Toxicol. Appl. Pharmacol. 194(3), 257-269.